Genmab's market cap is currently $14.18B. The company's EPS TTM is $1.769; its P/E ratio is 12.68; Genmab is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $0.23. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	kr 16.47B	kr 14.60B	kr 8.48B	kr 10.11B	kr 5.37B
Gross Profit	kr 16.25B	kr 14.60B	kr 8.48B	kr 10.11B	kr 5.37B
Operating Income	kr 5.32B	kr 6.36B	kr 3.02B	kr 6.31B	kr 2.64B
EBITDA	kr 5.56B	kr 7.04B	kr 3.15B	kr 6.54B	kr 2.78B
Net Income	kr 4.35B	kr 5.45B	kr 2.96B	kr 4.76B	kr 2.17B
Balance Sheet
Cash & Short-Term Investments	kr 28.14B	kr 22.32B	kr 19.34B	kr 16.08B	kr 10.97B
Total Assets	kr 35.29B	kr 30.28B	kr 24.63B	kr 21.14B	kr 15.14B
Total Debt	kr 770.00M	kr 597.00M	kr 425.00M	kr 319.00M	kr 181.00M
Net Debt	kr -14.10B	kr -9.30B	kr -8.53B	kr -6.94B	kr -3.37B
Total Liabilities	kr 3.68B	kr 2.84B	kr 2.43B	kr 2.02B	kr 1.10B
Stockholders' Equity	kr 31.61B	kr 27.44B	kr 22.20B	kr 19.12B	kr 14.05B
Cash Flow
Free Cash Flow	kr 7.00B	kr 3.60B	kr 1.98B	kr 6.13B	kr 1.22B
Operating Cash Flow	kr 7.38B	kr 3.91B	kr 2.23B	kr 6.43B	kr 1.33B
Investing Cash Flow	kr -1.28B	kr -2.76B	kr -961.00M	kr -2.35B	kr -1.98B
Financing Cash Flow	kr -606.00M	kr -789.00M	kr -420.00M	kr 71.00M	kr 3.66B

Currency in DKK

Genmab Earnings and Revenue History

Income Statement >

Genmab Debt to Assets

Balance Sheet >

Genmab Cash Flow

Cash Flow >

Genmab Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing